Literature DB >> 16733717

Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations.

Marija Velickovic1, Zlatibor Velickovic, Heather Dunckley.   

Abstract

Killer immunoglobulin-like receptors (KIRs) regulate the activity of NK and T cells through interaction with specific HLA class I molecules on target cells. To date, 16 KIR genes and pseudogenes have been identified. Diversity in KIR gene content and KIR allelic and haplotype polymorphism has been observed between different ethnic groups. Here, we present data on the KIR gene distribution in Pacific Islands populations. Sixteen KIR genes were observed in Pacific Islands populations from the Cook Islands, Samoa, Tokelau, and Tonga. The majority of KIR genes were present at similar frequencies between the four populations with KIR2DL4, KIR3DL2, and KIR3DP1 genes observed in all individuals. Commonly observed KIR genes in Pacific Islands populations (pooled frequencies) were KIR2DL1 (0.77), KIR2DL3 (0.77), KIR3DL1 (0.65), KIR3DL3 (0.93), KIR2DS4/1D (0.78), and KIR2DP1 (0.82), compared to the less-frequently observed KIR2DL2 (0.27), KIR2DL5 (0.30), KIR2DS1 (0.19), KIR2DS2 (0.27), KIR2DS3 (0.16), KIR2DS5 (0.17), and KIR3DS1 (0.18) genes. Differences in KIR gene frequency distributions were observed between the Pacific Islands populations and when compared to other populations. Sixty-nine different genotypes were identified, with five genotypes accounting for more then 50% of all genotypes observed. The number of genotypes observed in each population was similar in the Cook Islands, Samoan, and Tokelauan populations (19, 18, and 19, respectively), but 26 different genotypes were observed in Tongans. The putative haplotype A was predominantly observed over haplotype B in all Pacific Islands populations. Significant linkage disequilibrium was observed for a number of KIR gene pairs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733717     DOI: 10.1007/s00251-006-0124-3

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  46 in total

1.  Genomic diversity of natural killer cell receptor genes in three populations.

Authors:  M Toneva; V Lepage; G Lafay; N Dulphy; M Busson; S Lester; A Vu-Trien; A Michaylova; E Naumova; J McCluskey; D Charron
Journal:  Tissue Antigens       Date:  2001-04

2.  Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules.

Authors:  R Biassoni; A Pessino; A Malaspina; C Cantoni; C Bottino; S Sivori; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1997-12       Impact factor: 5.532

3.  HLA-DPA1 and DPB1 polymorphism in four Pacific Islands populations determined by sequencing based typing.

Authors:  Z M Velickovic; J M Carter
Journal:  Tissue Antigens       Date:  2001-06

4.  HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.

Authors:  M Colonna; G Borsellino; M Falco; G B Ferrara; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

5.  Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions.

Authors:  S J Mack; T L Bugawan; P V Moonsamy; J A Erlich; E A Trachtenberg; Y K Paik; A B Begovich; N Saha; H P Beck; M Stoneking; H A Erlich
Journal:  Tissue Antigens       Date:  2000-05

6.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

7.  Haplotype analysis of killer cell immunoglobulin-like receptor genes in 77 Korean families.

Authors:  Dong Hee Whang; Hyejin Park; Jung Ah Yoon; Myoung Hee Park
Journal:  Hum Immunol       Date:  2005-02       Impact factor: 2.850

8.  Determinants of antileukemia effects of allogeneic NK cells.

Authors:  Wing Leung; Rekha Iyengar; Victoria Turner; Peter Lang; Peter Bader; Paul Conn; Dietrich Niethammer; Rupert Handgretinger
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

9.  Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002.

Authors:  Steven G E Marsh; Peter Parham; Bo Dupont; Daniel E Geraghty; John Trowsdale; Derek Middleton; Carlos Vilches; Mary Carrington; Campbell Witt; Lisbeth A Guethlein; Heather Shilling; Christian A Garcia; Katharine C Hsu; Hester Wain
Journal:  Immunogenetics       Date:  2003-06-28       Impact factor: 2.846

10.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

View more
  16 in total

1.  Amazonian Amerindians exhibit high variability of KIR profiles.

Authors:  Paloma Daguer Ewerton; Mauro de Meira Leite; Milena Magalhães; Leonardo Sena; Eduardo José Melo dos Santos
Journal:  Immunogenetics       Date:  2007-06-06       Impact factor: 2.846

2.  Diversity of killer cell immunoglobulin-like receptor genes in four ethnic groups in China.

Authors:  Yufeng Yao; Lei Shi; Yufen Tao; Keqin Lin; Shuyuan Liu; Liang Yu; Zhaoqing Yang; Wen Yi; Xiaoqin Huang; Hao Sun; Jiayou Chu; Li Shi
Journal:  Immunogenetics       Date:  2011-05-10       Impact factor: 2.846

3.  KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.

Authors:  Neda Nemat-Gorgani; Hisham A Edinur; Jill A Hollenbach; James A Traherne; Paul P J Dunn; Geoffrey K Chambers; Peter Parham; Paul J Norman
Journal:  Immunogenetics       Date:  2014-08-21       Impact factor: 2.846

4.  Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.

Authors:  Zeying Du; David W Gjertson; Elaine F Reed; Raja Rajalingam
Journal:  Immunogenetics       Date:  2006-11-14       Impact factor: 2.846

5.  The diversity of KIR gene in Chinese Northern Han population and the impact of donor KIR and patient HLA genotypes on outcome following HLA-identical sibling allogeneic hematopoietic stem cell transplantation for hematological malignancy in Chinese people.

Authors:  Li Ping Dou; De Hua Zheng; Chang Wang; Jun Hua Liu; Jing Fen Sun; Hai Jie Jin; Chun Ji Gao; Li Yu; Wan Ming Da
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

6.  Comparison of the rapidly evolving KIR locus in Parsis and natives of India.

Authors:  S Kulkarni; R M Single; M P Martin; R Rajalingam; R Badwe; N Joshi; M Carrington
Journal:  Immunogenetics       Date:  2008-03-20       Impact factor: 2.846

7.  Distinct diversity of KIR genes in three southern Indian populations: comparison with world populations revealed a link between KIR gene content and pre-historic human migrations.

Authors:  Raja Rajalingam; Zeying Du; Ashley Meenagh; Lihui Luo; Valampuri John Kavitha; Rajamanickam Pavithra-Arulvani; Arumugam Vidhyalakshmi; Surendra K Sharma; Ivan Balazs; Elaine F Reed; Ramasamy M Pitchappan; Derek Middleton
Journal:  Immunogenetics       Date:  2008-03-28       Impact factor: 2.846

8.  KIR3DL1/S1 genotypes and KIR2DS4 allelic variants in the AB KIR genotypes are associated with Plasmodium-positive individuals in malaria infection.

Authors:  Michiko Taniguchi; Masato Kawabata
Journal:  Immunogenetics       Date:  2010-01-05       Impact factor: 2.846

9.  Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3.

Authors:  Lihui Luo; Zeying Du; Surendra K Sharma; Rebecca Cullen; Stephen Spellman; Elaine F Reed; Raja Rajalingam
Journal:  Immunogenetics       Date:  2007-07-24       Impact factor: 2.846

10.  KIR gene content diversity in four Iranian populations.

Authors:  Elham Ashouri; Shirin Farjadian; Elaine F Reed; Abbas Ghaderi; Raja Rajalingam
Journal:  Immunogenetics       Date:  2009-06-12       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.